13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease
Year: 2015
Type: article
Study design: Observational Study
Authors: Deborah Elstein, Aya Abrahamov, Anat Oz, Naama Arbel, Hagit Baris, Ari Zimran
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1799173174
